Microlaryngoscopy Tube (MLT) segmentation by application reflects the clinical breadth of the device, dividing usage into diagnostic laryngoscopy, therapeutic laser surgery, oncologic tumor resection, and pediatric airway reconstruction. Diagnostic laryngoscopy employs MLTs primarily for visualization and biopsy, supporting routine ENT examinations and contributing a stable, volume‑driven share of the market. Therapeutic laser surgery, the largest segment, leverages the tube’s precision channeling to deliver laser energy for vocal cord lesions, accounting for the highest revenue due to higher procedure reimbursement rates. Oncologic tumor resection utilizes specialized, often larger‑diameter tubes to access subglottic malignancies, representing a niche but high‑margin portion of the market. Pediatric airway reconstruction demands smaller, flexible tubes designed for infant anatomy, generating a modest yet growing share as congenital airway disorders gain diagnostic attention. This application‑focused taxonomy underpins strategic product development and aligns R&D investment with the most lucrative clinical pathways.